B6.129P2-Sema3etm1Ddg/Orl

Status

Available to order

EMMA IDEM:01373
Citation informationRRID:IMSR_EM:01373 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.129P2-Sema3etm1Ddg/Orl
Alternative nameSema3E
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolSema3etm1Ddg
Gene/Transgene symbolSema3e

Information from provider

ProviderChristopher Henderson
Provider affiliationINSERM UMR 623 - IBDM
Genetic informationThe first coding exon of mouse Sema3e encodes the signal peptide. In the targeting vector, a DNA fragment encoding the green fluorescent protein EGFP is inserted exactly at the start codon of the Sema3e gene. The vector also contains a neo cassette flanked by loxP sites for ES cell selection. This vector was used to target the Sema3e locus by homologous recombination in ES cells and generate the mutant locus. Recombinant ES cells were injected into C57BL/6 blastocysts. Chimeric founders were bred to C57BL/6 mice, and heterozygous mice were crossed with cre recombinase-expressing mice in order to delete the neo-cassette. Finally heterozygous mice were used to establish lines that were backcrossed to either a C57BL/6 or a CD1 genetic background.
Phenotypic informationnothing
Breeding historyFive backcrosses to C57BL/6.
References
  • Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins.;Gu Chenghua, Yoshida Yutaka, Livet Jean, Reimert Dorothy V, Mann Fanny, Merte Janna, Henderson Christopher E, Jessell Thomas M, Kolodkin Alex L, Ginty David D, ;2005;Science (New York, N.Y.);307;265-8; 15550623

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France
Animals used for archivingheterozygous C57BL/6J males, wild-type C57BL/6J females

Disease and phenotype information

IMPC phenotypes (gene matching)
  • persistence of hyaloid vascular system / IMPC
  • irregularly shaped pupil / IMPC
  • decreased circulating phosphate level / IMPC
  • impaired pupillary reflex / IMPC
  • abnormal placement of pupils / IMPC
  • abnormal retina blood vessel morphology / IMPC
  • abnormal retina morphology / IMPC
  • abnormal locomotor behavior / IMPC
MGI phenotypes (allele matching)
  • abnormal retina morphology / MGI
  • abnormal retinal vasculature morphology / MGI
  • abnormal somite development / MGI
  • abnormal intersomitic vessel morphology / MGI
MGI phenotypes (gene matching)
  • abnormal motor neuron morphology / MGI
  • abnormal motor neuron innervation pattern / MGI
  • abnormal retina morphology / MGI
  • abnormal somite development / MGI
  • abnormal retinal vasculature morphology / MGI
  • nervous system phenotype / MGI
  • behavior/neurological phenotype / MGI
  • abnormal intersomitic vessel morphology / MGI
  • Bergmeister's papilla / MGI

Literature references

  • Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins.;Gu Chenghua, Yoshida Yutaka, Livet Jean, Reimert Dorothy V, Mann Fanny, Merte Janna, Henderson Christopher E, Jessell Thomas M, Kolodkin Alex L, Ginty David D, ;2005;Science (New York, N.Y.);307;265-8; 15550623
  • Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice.;Fukushima Yoko, Okada Mitsuhiro, Kataoka Hiroshi, Hirashima Masanori, Yoshida Yutaka, Mann Fanny, Gomi Fumi, Nishida Kohji, Nishikawa Shin-Ichi, Uemura Akiyoshi, ;2011;The Journal of clinical investigation;121;1974-85; 21505259

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).